Why Silver Bullet?
Paul Chirico, President & CEO
There is a significant clinical need to prevent bacteria from contaminating patients upon medical device implantation.
Silver Bullet Therapeutics has developed OrthoFuzIon™ with Galvanis2, a regulatory-cleared silver ionization coating for an antimicrobial device implant.
The CMS “Bundled Payments for Care Improvement” (BPCI) may be a dramatic driving force for market adoption of OrthoFuzIon™ and Galvanis™ technology.
Six years of development, testing and animal trials have enabled us to perfect our technology.
Click here for Company Fact Sheet
About Silver Bullet
Silver Bullet is developing OrthoFuzIon™ with Galvanis™, an antimicrobial coating based on proprietary silver ionization technology designed to prevent contaminations associated with medical device implants.
Houdin Dehnad, Ph.D.
Focus on implant material design in embolic coils, stents and polymer materials
Bohdan Chopko, MD, PhD